Document is current
Any future updates will be listed below
-
Authors
Camenisch, Selina
Bell, Luisa
Stokar-Regenscheit, Nadine
Char, Natalia Vélez
Jochum, Wolfram
Heinze, Simon
Zeitlberger, Anna Maria
Hundsberger, Thomas
Neidert, Marian
Wick, Peter
Ayala-Nunez, Vanesa
-
Funding
Funding for this research was provided by:
Empa - Swiss Federal Laboratories for Materials Science and Technology
- License Information
-
More Information
Article History
Received: 22 April 2026
Accepted: 23 August 2026
First Online: 1 September 2026
Declarations
Ethics approval and consent to participate: This study was conducted in accordance with all relevant ethical regulations. Ethical approval for the experimental use of surplus tumor tissue was granted by the Swiss Ethics Committee (BASEC Nr. 2021–00475), and anonymized tissue samples were provided by the Department of Neurosurgery, Hospital St. Gallen.
Consent for publication: During their initial surgical admission, all patients provided written informed consent for the storage and future research use of their residual biological material, as well as for the publication of study results, in accordance with local ethical requirements.
Competing interests: L.B and N.S.-R. were employees and shareholders of F. Hoffmann-La Roche Ltd at the time the work was completed.
